Erhaltungstherapie Mit Histamindihydrochlorid Plus IL-2

Best Practice Onkologie - Germany
doi 10.1007/bf03359750
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors

Unknown

Publisher

Springer Science and Business Media LLC